Alzheimer's Disease News and Research

RSS

Alzheimer's disease (AD) is an irreversible, progressive brain disease that slowly destroys memory and thinking skills and, eventually, the ability to carry out the simplest tasks of daily living. In most people with AD, symptoms first appear after age 60. AD is the most common cause of dementia among older people, but it is not a normal part of aging. Dementia refers to a decline in cognitive function that interferes with daily life and activities. AD starts in a region of the brain that affects recent memory, then gradually spreads to other parts of the brain. Although treatment can slow the progression of AD and help manage its symptoms in some people, currently there is no cure for this devastating disease.

Researchers report unusually high levels of herpesvirus in the brains of people with Alzheimer's disease

Two strains of human herpesvirus - human herpesvirus 6A (HHV-6A) and human herpesvirus 7 (HHV-7) - are found in the brains of people with Alzheimer's disease at levels up to twice as high as in those without Alzheimer's, researchers from the Icahn School of Medicine at Mount Sinai report.

21 Jun 2018

Breakthrough discovery reveals brain metals that may drive progression of Alzheimer’s disease

Alzheimer's disease could be better treated, thanks to a breakthrough discovery of the properties of the metals in the brain involved in the progression of the neurodegenerative condition, by an international research collaboration including the University of Warwick.

21 Jun 2018

Aquinnah Pharmaceuticals wins NINDS grant to advance novel therapies for ALS

Aquinnah Pharmaceuticals, leaders in stress granule biology, an exciting new target for the development of neurodegenerative therapeutics, announced today that it has been awarded $3.4 million from the National Institute of Neurological Disorders and Stroke in a competing grant to advance novel therapeutic drug candidates towards the clinic for treating patients with amyotrophic lateral sclerosis, also known as Lou Gehrig's disease.

21 Jun 2018

Simple, cost-effective test may help improve early diagnosis of mild cognitive impairment

An international team of scientists have developed a new way to screen for age-related cognitive decline at home using a test which asks people to detect sounds and flashes on their laptop or phone.

21 Jun 2018

Impulse control disorders found to be more common in people taking Parkinson's drugs

Over time, half of the people taking certain drugs for Parkinson's disease may develop impulse control disorders such as compulsive gambling, shopping or eating, according to a study published in the June 20, 2018, online issue of Neurology®, the medical journal of the American Academy of Neurology.

20 Jun 2018

Researchers employ nucleotide-based gene silencing to mitigate common ataxia

In what researchers are calling a game changer for future ataxia treatments, a new study showed the ability to turn down the disease progression of the most common dominantly inherited ataxia.

20 Jun 2018

Researchers invent medical device for proliferation, differentiation of neural stem cells

The research team of Hong Kong Baptist University invented a medical device with a specific nanotechnology layer for the proliferation and differentiation of neural stem cells in vitro.

20 Jun 2018

Patients with mild Alzheimer's disease over age 65 continue to derive benefit from DBS-f treatment

An age group analysis of data from the ADvance trial has shown that participants over the age of 65 continue to derive the most benefit from Deep Brain Stimulation of the fornix, as observed in the data from the phase 2 findings (12 - 24 months) of the Phase II trial.

19 Jun 2018

Scientists obtain key information about proteins from single human cells

Scientists have obtained a slew of key information about proteins, the molecular workhorses of all cells, from single human cells for the first time.

19 Jun 2018

Study hints at benefits of lifestyle interventions in reducing dementia risk

There is no treatment yet for dementia; but one day, a family doctor could prescribe a specific diet, an exercise regime, music or language lessons, or documentary discussion groups as treatments to ward off the disease.

19 Jun 2018

Researchers discover new defense mechanism against oxygen radicals

Oxygen radicals occur as a by-product when living beings burn carbohydrates or fat. They are suspected of accelerating the ageing process in humans and animals, and to be partly responsible for severe illnesses such as Alzheimer's or certain types of cancer.

18 Jun 2018

Scientists to focus on big data and genetics to identify risk factors for dementia

Physical activity plays an important part in dementia prevention. In order to identify risk factors for this neurological disease more effectively, scientists will increasingly focus on big data and genetic research, experts reported at the Congress of the European Academy of Neurology in Lisbon.

18 Jun 2018

New study focuses on best, cost effective practices to bridge treatment gap for brain disorders

Up to eight out of ten patients with a brain disorder remain untreated or inadequately treated. But what is the best practice - and above all, most cost effective - healthcare interventions to bridge the treatment gap? This was the focus of the European Brain Council's study entitled The Value of Treatment which was discussed at the Congress of the European Academy of Neurology in Lisbon.

18 Jun 2018

Zika Virus: What Does the Future Hold?

Following the Zika virus epidemic that swept across Brazil between 2015-2016, Dr. Julia Clarke and her team begun working to establish the long-term effects of Zika, and recently discovered that TNF-a inhibitors can be used to prevent microencephaly.

18 Jun 2018

People with type 2 diabetes may have increased risk of Parkinson's disease, shows study

People with type 2 diabetes may have an increased risk of having a diagnosis of Parkinson's disease later in life, according to a large study published in the June 13, 2018, online issue of Neurology®, the medical journal of the American Academy of Neurology.

14 Jun 2018

Waste-disposal system of cell appears to play key role in spread of Alzheimer's disease

The waste-disposal system in a cell can spread harmful protein aggregates between neurons in the brain in Alzheimer's disease, according to researchers at Linköping University, Sweden.

13 Jun 2018

Study shows how amyloid aggregates alter brain cells in Alzheimer’s disease

A new study has revealed the mechanism through which amyloid peptide aggregates alter brain cells to cause the harmful effects seen in Alzheimer’s disease.

12 Jun 2018

Combination of physical fitness and aortic stiffness explains rate of memory decline in older people

The rate of decline in certain aspects of memory may be explained by a combination of overall physical fitness and the stiffness of the central arteries, researchers from Swinburne's Centre for Human Psychopharmacology have found.

12 Jun 2018

Improving the quality of American's diet could reduce health-related costs, suggests study

What we eat has important implications for our health - and for what we spend on healthcare. New research suggests improving the quality of the average American's diet could substantially reduce costs associated with heart disease, diabetes, cancer and other major health problems.

11 Jun 2018

Researchers investigate role of glutamate in age-associated cognitive disorders

As people around the world live longer, the prevalence of age-associated cognitive disorders is growing. Alzheimer's disease, for which advanced age is the most significant risk factor, currently defies all therapeutic efforts.

8 Jun 2018

Alzheimer's Disease News and Research

Further Reading

Researchers report unusually high levels of herpesvirus in the brains of people with Alzheimer's disease

Breakthrough discovery reveals brain metals that may drive progression of Alzheimer’s disease

Aquinnah Pharmaceuticals wins NINDS grant to advance novel therapies for ALS

Simple, cost-effective test may help improve early diagnosis of mild cognitive impairment

Impulse control disorders found to be more common in people taking Parkinson's drugs

Researchers employ nucleotide-based gene silencing to mitigate common ataxia

Researchers invent medical device for proliferation, differentiation of neural stem cells

Patients with mild Alzheimer's disease over age 65 continue to derive benefit from DBS-f treatment

Scientists obtain key information about proteins from single human cells

Study hints at benefits of lifestyle interventions in reducing dementia risk

Researchers discover new defense mechanism against oxygen radicals

Scientists to focus on big data and genetics to identify risk factors for dementia

New study focuses on best, cost effective practices to bridge treatment gap for brain disorders

Zika Virus: What Does the Future Hold?

People with type 2 diabetes may have increased risk of Parkinson's disease, shows study

Waste-disposal system of cell appears to play key role in spread of Alzheimer's disease

Study shows how amyloid aggregates alter brain cells in Alzheimer’s disease

Combination of physical fitness and aortic stiffness explains rate of memory decline in older people

Improving the quality of American's diet could reduce health-related costs, suggests study

Researchers investigate role of glutamate in age-associated cognitive disorders

Human iPSCs: A Full Guide to Advanced in Vitro Models and Applications eBook

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Applications Engineer

Latest News